Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 15Triptorelin literatureLeukemia & lymphoma · Observational2008

Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma.

Triptorelin may help preserve ovarian function in young women undergoing chemotherapy for Hodgkin lymphoma, with 82% recovering regular menses.

Read at Leukemia & lymphomaAdd to compare

Where it sits

this study against the rest of the triptorelin corpus
1
Preclinical
10
Observational · this one
0
Open-label
3
Randomised
1
Reviews

Summary and findings

This study assessed the impact of triptorelin on treatment-related ovarian failure in 61 women with Hodgkin lymphoma undergoing chemotherapy from 1994 to 2006. The study reported that 50 patients (82%) recovered regular menses, while 13 patients who attempted conception were able to conceive. The findings suggest a correlation between age, disease stage, and ovarian failure.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
50 patients (82%) recovered regular menses.2008

Abstract

The authors’ words, as Leukemia & lymphoma supplied them

We conducted a retrospective study on treatment-related ovarian failure in 61 women with Hodgkin lymphoma who were under treatment from 1994 to 2006. To minimize the risk of treatment-related gonadotoxicity, triptorelin (Decapeptyl), a gonadotropin-releasing hormone analog (GnRHa), was administered monthly. All patients were treated with frontline polychemotherapy with or without radiotherapy. Seven refractory or relapsed patients received salvage treatment, and six of these patients further received peripheral blood stem cell transplantation. Fifty patients (82%) recovered regular menses, four patients (6%) reported menstrual abnormalities, and seven patients (12%) who were under salvage treatment became amenorrheic. We found a clear correlation between age at the time of treatment, advanced disease, cumulative therapeutic load and ovarian failure. After the completion of treatment, 13 patients who attempted conception conceived. GnRHa may preclude ovarian damage and infertility in young women receiving frontline polychemotherapy alone or in combination with supradiaphragmatic radiotherapy. In refractory or relapsed patients, GnRHa does not seem to be very effective, and further experimental approaches are required for fertility preservation.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Triptorelin corpus

CDevelopment and Preclinical Evaluation of Six-Transmembrane Epithelial Antigen of Prostate 2 Targeted PET Probes: A Case of Drug Repurposing Based on Molecular Docking.Journal of medicinal chemistry · 2016 · SUVmax 1.8 in 22Rv1 xenografts for 68Ga-Trip-5.AnimalBOvarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2002 · Bilateral ovarian enlargement: right 74 x 62 mm, left 62 x 53 mm.HumanASignificance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial.Scandinavian journal of urology and nephrology · 2011 · 33% of patients with pretreatment cardiovascular diseases had a cardiovascular event during PEP treatment.HumanAThe two-shot protocol. A randomized controlled trial of a novel two-injection ovarian stimulation strategy.Human reproduction (Oxford, England) · 2023 · n=194 · Mean number of MII oocytes: 8.09 ± 5.87 vs 9.11 ± 6.86; MD -1.02 [95% CI: -2.83; 0.79]HumanAComparative effectiveness of luteal phase support strategies in natural cycle frozen-thawed embryo transfer: a systematic review and network meta-analysis.European journal of obstetrics, gynecology, and reproductive biology · 2026 · Not reported in abstract.reviewCProposed Method for Mass Spectrometric Measurement of the Gonadotropin-Releasing Hormone Agonist Deslorelin.Toxics · 2026 · Detectability optimized to <1 ppb.Animal